Showing results (911-920 of 962) with videos related to
Sort By:
Pageof 97
Journal of Diabetes Investigation|August 22, 2024
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrateAndrzej S Januszewski, Hayden K Young, Kwok-Leung Ong, et al.Heart Rhythm|May 7, 2026
A new mapping and ablation strategy for premature ventricular complexes originating from the proximal left anterior fascicle under the guidance of electrocardiographic characteristicsXiaofeng Lu, Shi Peng, Wenhua Li, et al.Bioinformatics (Oxford, England)|September 14, 2014
Improved rat genome gene prediction by integration of ESTs with RNA-Seq informationLiping Li, Enguo Chen, Chun Yang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 10, 2025
Novel Quaternary Ammonium Salt-Linked STING Agonist Antibody-Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off-Target ToxicityYu Long, Borui Tang, Fei Xie, et al.Cancers|May 15, 2019
The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40Veronika Caisova, Liping Li, Garima Gupta, et al.Nature Communications|January 21, 2026
Decidualization-empowered ECM hydrogel integrating sustained Tβ4 release drives endometrial regeneration in intrauterine adhesionsYuxiang Liang, Zhaowei Yu, Shaobo Du, et al.Signal Transduction and Targeted Therapy|April 17, 2020
A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathwayKang Lu, Bo Li, Hui Zhang, et al.Biorxiv : the Preprint Server for Biology|October 3, 2025
Role of tankyrase scaffolding in the β-catenin destruction complex and WNT signalingQian Wang, Liping Li, Lin You, et al.ACS Catalysis|October 23, 2018
Catalytic Role of Conserved Asparagine, Glutamine, Serine, and Tyrosine Residues in Isoprenoid Biosynthesis EnzymesSatish R Malwal, Jian Gao, Xiangying Hu, et al.Medcomm|February 14, 2025
Once-weekly glucagon-like peptide receptor agonist polyethylene glycol loxenatide protects against major adverse cardiovascular events in patients with type 2 diabetes: a multicenter ambispective cohort study (FLYING trial)Jilin Li, Yu Tian, Liping Li, et al.Pageof 97